Introduction
Influenza is a highly contagious and acute respiratory disease caused by influenza virus infection of the upper or lower respiratory tract of the host (Murphy & Webster, 1996 ; Wilson & Cox, 1990 ; Mayer et al., 1978) . The site of infection can be correlated with the severity of disease caused by influenza virus, which can range from no apparent infection through mild respiratory infection and tracheobronchitis to severe viral pneumonia. In addition, the site of infection can influence the immune response of the host and modify immunity status (Murphy & Webster, 1996 ; Yetter et al., 1980) . To assess immune status and the lymphoid organ involvement in immunity, experimental infection of mice has been used. Jones & Ada (1986) first demonstrated that, in response to lower respiratory tract infection, the lungs themselves provide antibody-forming cells (AFCs) capable of generating antibody (Ab). However, the responses of AFCs in the upper respiratory tract following infection are less well understood.
Author for correspondence : Shin-ichi Tamura. Recently the paired lymphoid cell aggregates of the rodent upper respiratory tract, named nasal-associated lymphoid tissue (NALT), have been recognized as the only wellorganized mucosal-associated lymphoid tissue in the upper respiratory tract (Spit et al., 1989 ; Koornstra et al., 1991 ; Kuper et al., 1992 ; van der Ven & Sminia, 1993) . NALT, which is the equivalent of Waldeyer's rings in humans, is situated just underneath the epithelium and consists of a reticular network filled with various types of lymphoid and non-lymphoid cells. NALT seems to be an important site in lymphocyte recirculation as NALT lymphocytes migrate back to NALT and cervical lymph nodes (CLNs) in far greater number than cells from Peyer's patches and, reciprocally, cells from the CLNs home more successfully to NALT than to Peyer's patches (Koornstra et al., 1991 ; Kuper et al., 1992) . The role that NALT lymphocytes play in immunity to influenza virus infection, however, remains to be elucidated. In order to investigate this, we developed a method for the isolation and characterization of mouse NALT (Asanuma et al., 1997) .
In the present experiments, the in vivo and in vitro kinetics of the influenza virus-specific AFC responses were examined in NALT of BALB\c mice. Mice were infected intranasally with a small volume of virus suspension, which restricts infection mainly to the upper respiratory tract (Yetter et al., 1986 ; Tamura et al., 1992 Tamura et al., a, 1996 , and specific AFC responses were examined. These experiments demonstrated that virus-specific AFC responses in NALT of infected mice were characterized by predominantly IgA-producing cells, which probably play a role in recovery from influenza infection. Additionally, NALT cells from uninfected mice were cultured in the presence of influenza virus. The specific IgM AFC responses seen following culture suggest that at least a portion of the AFCs observed following infection originate from specific B cell precursors in NALT.
Methods
Animals. Inbred 6-to 10-week-old BALB\c female mice obtained from Japan SLC (Hamamatsu-shi) were used in this study.
Infection. Mice were infected with influenza virus A\PR\8\34 (PR8 ; H1N1) by dropping 1n0 µl of a virus suspension containing 10%
e. total volume of 2 µl) under light anaesthesia (Tamura et al., 1996) . This infection procedure induced early nasal and late lung infection.
Preparation of NALT lymphocytes. NALT lymphocytes were isolated by a method previously described (Asanuma et al., 1997) . Mice were anaesthetized with chloroform and then bled from the heart with a syringe. After exsanguination, the head of the mouse was cut off along the line between the upper and lower jaw. The facial skin was stripped from the head and the nose part was separated from the rest of the head along the line of the eyeballs. The tip of the nose containing the foreteeth was cut off. After removing cheek muscles, cheek bones and back teeth, the remaining nose part contained the nasal turbinates, septum, lateral walls and palate. NALT was separated from the rest of the nasal tissue by peeling away the palate. NALT is localized bilaterally on the posterior side of the palate ; after obtaining the palate, the palate tip and lower half (which did not contain NALT) were cut off. The NALT fragment was teased gently between frosted glass slides and NALT lymphocytes were released in 0n15 M phosphate buffer (pH 7n2) (Stavitsky, 1954) and passed through a stainless-steel mesh. The NALT lymphocyte population thus obtained is mainly composed of lymphocytes with some contaminating erythrocytes and destroyed epithelial cells.
Non-NALT nasal lymphocyte preparation. Non-NALT nasal lymphocytes were prepared from the portion of the nasal cavity (nasal turbinates, septum and lateral walls) remaining after isolation of the NALT according to the method described previously (Asanuma et al., 1995) . They probably contained lymphocytes from paired small lymphoid nodules near the periorbital regions, lymphocytes in the lamina propria and intraepithelial lymphocytes.
Preparation of lymphocytes from other lymphoid organs.
Posterior and superficial CLN lymphocytes (Tilney, 1971 ) and splenocytes were prepared by pressing small fragments of each organ between frosted glass slides (Tamura et al., 1981) .
Flow cytometry. Flow cytometry analyses were performed using a FACScan flow cytometer and Lysis II software (Becton Dickinson). Approximately 2i10& cells per sample were stained for 30 min with a concentration of polyclonal Abs or MAbs titrated to maximize staining and limit background interference (Asanuma et al., 1997) . The following MAbs (all obtained from Pharmingen), coupled to FITC or phycoerythrin, were used for staining : anti-CD3ε (CD3) (145-2C11), anti-L3T4 (CD4) (RM4-5), anti-Ly-2 (CD8) (53-8.7) and anti-B220 (RA3-6B2). Dead cells were excluded from analysis on the basis of propidium iodide (Molecular Probes) staining.
Enzyme-linked immunospot (ELISPOT) assay. Influenza virus haemagglutinin (HA)-specific Ab-secreting cells were enumerated by ELISPOT assay (Czerkinsky et al., 1983 ; Lycke, 1986) . Briefly, a 96-well plate with a nitrocellulose base (Millitier HA ; Millipore) was coated overnight at 4 mC with PR8 HA vaccine, prepared from virus by the method of Davenport et al. (1964) in the Kitasato Institute, at a concentration of 10 µg\ml (100 µl per well). All wells were then blocked with 5 % FCS in PBS for 60 min at room temperature. Lymphocytes (2-10i10' cells) were suspended in Iscove's modified Dulbecco's medium containing 5 % FCS and diluted serially from 1\2! to 1\2%. The diluted lymphocytes were added to each well (100 µl\well) and incubated for 3-4 h at 37 mC in 5% CO # in air. The plate was thoroughly washed with PBS-Tween and then incubated for 2 h at room temperature with 100 µl goat anti-mouse IgA (α chain-specific) (Life Technologies), goat anti-mouse IgG (γ chain-specific) (Southern Biotechnology Associates) or goat anti-mouse IgM (µ chain-specific) (Life Technologies) conjugated with alkaline phosphatase. Spots representing single Ab-secreting cells were developed with the substrate (a buffered solution containing 2n5 mg\ml 5-bromo-4-chloro-3-indolyl phosphate and 1n0 mg\ml nitro blue tetrazolium, Sigma). The spots were counted with the aid of a dissecting microscope. The specificity of the ELISPOT assay for detecting influenza virus-specific AFCs has been described previously (Jones & Ada, 1986 ; Asanuma et al., 1997) .
NALT and spleen cell cultures. NALT and spleen cell suspensions from normal mice containing 5i10' cells per ml were cultured in 200 µl RPMI 1640 medium containing 10 % FCS, 5i10 −& M 2-mercaptoethanol and antibiotics in flat-bottomed, 96-well culture plates (Nunc). The plates were incubated at 37 mC in 5% CO # . Cultures were stimulated by addition of a virus suspension containing 10( n " EID &! , which was the optimal concentration for in vitro stimulation of normal spleen cells. The specificity of AFCs generated in vitro was similar to that of AFCs in vivo.
Specimens. Mice were anaesthetized with chloroform and then bled from the heart with a syringe. After bleeding, they were incised ventrally along the median line from the xiphoid process to the point of the chin. The trachea and lungs were taken out and washed twice by inflating the lungs with a total of 2 ml PBS containing 0n1 % BSA (Balkovic & Six, 1986) . The bronchoalveolar wash was used for virus titration after the removal of cellular debris by centrifugation. The head of the mouse was removed and the lower jaw was cut off. A syringe needle was inserted into the posterior opening of the nasopharynx and then a total of 1 ml PBS containing 0n1 % BSA was injected into the opening three times ; the outflow was collected as nasal wash. The nasal wash was centrifuged to remove cellular debris and used for virus titration.
ELISA. The amounts of IgA and IgG Ab against HA molecules purified from PR8 virus were measured by ELISA (Tamura et al., 1992 b) . ELISA was performed sequentially from the solid phase (EIA plate ; Coster) with a ladder of reagents consisting of (in order) : first, HA molecules (1 µg\ml) purified from PR8 virus according to the procedure of Phelan et al. (1980) ; then nasal wash or serum ; then goat anti-mouse IgA (α-chain specific ; 1 : 1000) (Amersham) or goat anti-mouse IgG (γ-chain specific ; 1 : 1000) (Amersham) conjugated with biotin ; then streptavidin conjugated with alkaline phosphatase (1 : 1000) (GIBCO BRL) ; and finally, p-nitrophenyl-phosphate (Sigma). The absorbance of Nasal antibody responses to influenza virus Nasal antibody responses to influenza virus the chromogen produced was measured at 410 nm in an SJ eia Autoreader (model er-8000 ; Sanko Junyaku). The purified HA-specific IgA or IgG at 100 ng\ml was used as a standard (Tamura et al., 1992 b) . The Ab concentration of an unknown specimen was determined from the standard regression curve constructed for each assay with the SJ eia Autoreader.
Virus titration. Serial 10-fold dilutions of the nasal washings were prepared. Each dilution was injected into five embryonated eggs (10-day embryonated eggs used for growing influenza viruses in the alantoic fluid) and the EID &! of each specimen was calculated (Tamura et al., 1988) .
Immunoprecipitation and RT-PCR.
The nasal wash pooled from each group of five mice (500 µl) was centrifuged at 1500 g for 3 min. Then, Ab-bound Sepharose (100 µl of a 1 : 1 slurry of Ab-Sepharose\PBS) was added to the precleared supernatant of nasal wash in order to precipitate the soluble immune complexes formed between Ab and virus. Ab-bound Sepharose was prepared by coupling goat anti-mouse IgG (prepared by immunizing mouse IgG molecules) (Cappel) to CNBractivated Sepharose (Pharmacia LKB) according to the manufacturer's instructions. The Ab-bound Sepharose added to the nasal wash was incubated for 2 h at room temperature with occasional shaking and centrifuged twice with 1 ml PBS containing 0n1 % Triton X-100 and twice with 1 ml PBS alone at 200 g for 5 s. After washing, RNA in the goat anti-mouse IgG-Sepharose containing nasal wash Ab-virus immune complexes was extracted using a guanidine isothiocyanate and phenolbased method (TRIZOL LS ; Life Technologies) following the manufacturer's instructions. The extracted RNA was then reverse transcribed into cDNA using a first-strand cDNA synthesis kit (Boehringer Mannheim) with a random hexanucleotide primer and avian myeloblastosis virus reverse transcriptase in a 20 µl reaction volume. The cDNA (5µl) was examined for presence of the PR8 viral genome by 40 amplification cycles (94 mC, 30 s ; 56 mC, 60 s ; 72 mC, 120 s) of PCR with 5h TGCGGGGAAGGATCCTAAGAAAAC 3h and 5h TTCCAACTC-CTTTGACTGCAGCAC 3h as forward and reverse primers, respectively, which amplify the nucleotide sequence of the PR8 NP gene between positions 297 and 607. The PR8 NP gene used was from plasmid pME18S-NP (Tamura et al., 1996) . The amplified products were electrophoresed on 2 % agarose gels and visualized by ethidium bromide staining.
Results

Cell recovery from NALT following influenza virus infection
The kinetics of the cellular accumulation in NALT of BALB\c mice were examined following intranasal infection with a small volume of influenza virus PR8 (H1N1). The kinetics were compared with those observed in the spleen, as well as other upper respiratory tract lymphoid populations, including the nasal non-NALT population and the posterior and superficial CLN lymphocytes (Fig. 1) . As shown in Fig.  1 (A) , the cellularity (cellular accumulation) of NALT reached its maximum (8i10& cells per mouse, a 2-fold increase compared with normal mice) around day 7, declined to a lower level (which was higher than the normal level) on day 14 and reached its minimum (nearly normal level) on day 21. The increase in cell number began as early as day 1 post-infection (p.i.) (data not shown). FACS analysis showed that the NALT lymphoid cell population from normal mice contained about The nasal non-NALT site population of normal mice contained approximately twice as many lymphocytes as the organized NALT. Following infection, the cellularity of the nasal non-NALT population increased significantly, peaking at day 7 at approximately twice the normal value (Fig. 1 B) . The composition of T and B cells in the non-NALT population, which was similar to that in the NALT of normal mice, was not changed significantly by influenza virus infection. The cellularity of the posterior CLNs (which contained about three times as many cells as normal NALT) increased significantly to 3-fold that of normal mice by day 7 p.i. and decreased to normal levels by day 21 (Fig. 1 C) . The posterior CLNs contained 10-20 % B cells regardless of the infection stage. The superficial CLNs (which contained about 20 times as many cells as normal NALT) showed a 3-fold increase in cellularity on day 7 after infection which decreased gradually thereafter (Fig.  1 D) . They contained 20-30 % B cells regardless of the infection stage. The number of cells recovered from spleen was not changed significantly after infection (data not shown). In summary, intranasal administration of a small volume of influenza virus induced a significant increase in cellularity of lymphoid populations of the upper respiratory tract but not of the spleen. The increased cellular accumulation was due to the increase of both T and B cell populations with the peak around day 7 p.i. and without significant changes in the T\B or CD4\CD8 ratios.
Influenza virus-specific AFC responses in NALT after infection
The time-course and Ig isotype pattern of AFC responses to influenza virus antigens in the NALT of mice infected intranasally with PR8 virus were investigated by the ELISPOT assay and compared with those in the nasal non-NALT population and posterior and superficial CLNs (Fig. 2) . Virusspecific AFC responses in NALT were first detected on day 5, peaked on day 7 and declined thereafter (Fig. 2 A) . The frequencies of the IgA and IgG AFCs on day 7 in the NALT were approximately equal, and this level was 4-fold higher than the frequency of IgM AFCs. A similar Ig isotype pattern and time-course of AFC responses was detected in the nasal non-NALT lymphocytes and posterior CLNs, although the magnitude of the responses was about 25 and 50 % of that in the NALT, respectively (Fig. 2 B, C) . In contrast, IgG AFCs were most frequent in the superficial CLNs on day 7 p.i., followed by IgM AFCs, then IgA AFCs (Fig. 2 D) . In the spleen, almost no AFC response was detected on day 7 and only low levels of IgG AFCs (about 20 AFCs per 10' cells) and IgA AFCs (about 10 AFCs per 10' cells) were detected on day 21 after infection (data not shown). In summary, intranasal administration with influenza virus induced AFC responses which appeared first on day 5, peaked on day 7 and decreased thereafter in the upper respiratory tract lymphoid tissues. The AFC responses in NALT were characterized by high frequencies of IgA AFCs and IgG AFCs and low frequencies of IgM AFCs, while the Ig isotype pattern differed in the superficial CLNs. In addition, the lag of AFC responses in the spleen compared to upper respiratory tract tissues suggests that in the early days following the intranasal infection, B cells present at or close to the site of infection were the first to be stimulated.
The percentages of IgA AFCs per total cells in each tissue on day 7 after infection were about 0n1 % for the isolated NALT, 0n01 % for non-NALT, 0n01 % for posterior CLNs and 0n001 % for superficial CLNs (Figs 1 and 2) . Thus, in terms of IgA AFC concentration, NALT was the most concentrated site in the upper respiratory tract. On the other hand, when considering the total IgA AFC number in each tissue, NALT contained approximately 500, non-NALT 200, posterior CLNs 1200 and superficial CLNs 6000. These data suggest that posterior or superficial CLNs, to which the lymphatic drainage of NALT or nasal non-NALT mucosa occurs predominantly (Koornstra et al., 1991 ; Kuper et al., 1992) , are important sites for the generation of IgA AFCs. Nasal antibody responses to influenza virus Nasal antibody responses to influenza virus 
Comparison of AFC responses between upper respiratory tract infection and intravenous immunization with influenza virus
Mice immunized intravenously with PR8 virus were examined for AFC responses in the NALT and spleen at 7 days p.i. Table 2 shows that no AFC responses were detected in NALT of mice immunized intravenously with the virus. The spleen-specific AFC responses consisted of predominantly IgM AFCs, fewer IgG AFCs (about a third of the level of IgM AFCs), and almost no IgA AFCs. Thus, the Ig isotype pattern of AFC responses to virus antigens varied depending on the inoculation site. The predominant IgA and IgG AFC responses and the low level of IgM AFC responses to virus antigens (Fig.  2 A) are confirmed as one of the characteristics of NALT of mice infected intranasally with a small volume of virus suspension.
Virus-specific AFC responses in primary in vitro culture of NALT cells
The potential of NALT lymphocytes from normal mice to generate specific AFC responses following exposure to influenza virus was examined by the culture of normal NALT lymphocytes with PR8 virus. The time-course and Ig isotype pattern of AFC responses to influenza virus were evaluated in the culture of NALT cells from normal mice infected with PR8 virus and compared with the culture of normal spleen cells infected with the virus (Fig. 3) . AFCs producing IgM in NALT cell cultures were detected on day 3, peaked on day 4 and declined gradually thereafter (Fig. 3 A) . In some cultures, only a small number of IgA AFCs (16p11 per 10' cells) were detected around day 4. IgM AFCs in spleen cell cultures were detected on day 2, peaked on day 3 and declined rapidly thereafter (Fig. 3 B) . The peak IgM response in spleen cell cultures was five times greater than that in NALT cell cultures. In addition, a low level of IgG AFCs was detected in spleen cell cultures around day 4 (Fig. 3 B) . These results suggest that at 
Virus titres and Ab responses in the nasal wash following influenza virus infection
The nasal wash of mice infected intranasally with PR8 virus was examined for the presence of infectious virus and also for the presence of Ab specific for influenza virus HA molecules. Fig. 4 (A) shows that virus titres in the nasal wash were first detected on day 1, peaked on day 4, started to decline from day 7 and were below the level of detection by day 11 p.i. Anti-PR8 HA IgA Ab was first detected in the nasal wash on day 5, increased gradually to its maximum level on day 11, and persisted through day 14 (Fig. 4 B) . The IgG Ab responses to PR8 HA molecules in the nasal wash increased from day 11 and continued to increase gradually to day 21, although the titres of IgG Ab were very low compared with the IgA Ab level up to day 14 (Fig. 4 B) . Serum IgG Ab responses to PR8 HA, S.-i. Tamura and others S.-i. Tamura and others which reached a 100-fold higher titre than the nasal wash IgA Ab on day 21, were detected first on day 5 and continued to increase to day 21 (data not shown). The decline of virus titres from day 5 correlated with the increase of the anti-HA IgA Ab titres from day 5, suggesting that virus was eliminated from the nasal cavity by reacting with Ab. They also suggest that the source of the IgA and IgG Ab responses to PR8 HA molecules in the nasal wash and serum are the antiviral AFCs detected in NALT, nasal non-NALT and CLNs (Fig. 2) .
Evidence of influenza virus clearance by nasal wash Ab around day 7 after infection
Immunoprecipitates of the nasal wash from infected mice were examined for the presence of the viral genome by RT-PCR to confirm the possibility that the antiviral Abs at 5-11 days after infection were involved in virus clearance from the nasal cavity due to formation of immune complexes. Nasal Fig. 5 . Detection of the viral genome of PR8 in immunoprecipitates of nasal washes from mice infected intranasally with PR8 virus by the RT-PCR method. Lanes 1 and 11 are 100 bp and 100 bp/20 bp DNA markers, respectively. Lane 2 is a negative control for RT-PCR. Lanes 3-6 are the amplified products of immunoprecipitates from the nasal wash samples obtained at 3, 7, 9 and 11 days after infection, respectively. The template for RT-PCR for lane 7 is anti-Ig Sepharose alone (negative control). Lane 8 is an immunoprecipitate of the sample on day 11 with anti-glutathione Sepharose as a control for immunoprecipitation. Lanes 9 and 10 are 500 pg and 50 fg RT-PCR products of the recombinant clone containing the PR8 NP gene in pME18S, respectively. The 311 bp indicated on the right side of lane 11 is the expected size of an amplified product from the database sequence of the viral genome of PR8 virus (GenBank accession no. JO2147).
wash samples collected from mice on days 3, 7, 9 and 11 after infection were immunoprecipitated with goat anti-mouse IgG (specific for mouse whole IgG molecules) Ab-bound Sepharose 4B. As controls, nasal wash samples from non-infected mice or day 11 nasal wash were precipitated with anti-mouse IgG Sepharose or the non-specific IgG Sepharose. The yields of amplified products of RT-PCR (expected size of 311 bp) were of the highest density in immunoprecipitates from day 7 nasal wash and were also high on day 9 p.i. (Fig. 5) . On the other hand, the yields of amplified product of the immunoprecipitates on days 3 and 11 were comparable to that from day 11 nasal wash which was precipitated with non-specific IgG-bound Sepharose. Thus, the amount of viral genome included in immune complexes from the day 7 and 9 p.i. was more than that observed in control groups. These results suggest that antiviral Abs in nasal wash 7-9 days after infection are involved in virus elimination from the nasal cavity due to formation of immune complexes.
In addition, goat anti-mouse IgG Ab, bound to Sepharose to adsorb virus complexes from the nasal wash, was specific for both light and heavy chains of mouse IgG and could react with IgA, as well as IgG, by attaching to the light chains of both molecules. Thus, together with the result that the major antiviral Abs in the nasal wash around day 7 p.i. were of the CJG IgA isotype (Fig. 4) , the present data suggest that antiviral IgA in the nasal wash could be principally responsible for virus elimination.
Discussion
The appearance and development of specific AFCs in NALT during influenza virus infection have been described for the first time in the present experiments. In mice infected intranasally with a small volume of influenza virus, NALT was the most concentrated site of virus-specific IgA AFCs among the upper respiratory tract lymphoid tissues on day 7 after infection ( Fig. 2) . The peak IgA AFC response in the NALT was also detected immunohistochemically, showing the abundant appearance of IgA-bearing cells in the lamina propria of NALT (data not shown). In parallel with the development of AFCs in NALT, virus-specific IgA Abs appeared in the nasal wash (Fig. 4 B) . Almost no AFC response was detected in the spleen in the early days after infection, showing that intranasal virus infection first stimulated B cells present in or close to the site of infection. Thus, virus-specific IgA AFCs in the NALT were responsible for the production of IgA Ab in the upper respiratory tract in the early days after infection.
The primary response to intranasal infection with a small volume of virus suspension was also characterized by low levels of IgM AFC responses in NALT (Fig. 2) . The low IgM AFC responses were also observed in the non-NALT and posterior CLNs but not in the superficial CLNs. On the other hand, high virus-specific IgM and IgG AFC responses were induced in the spleen after primary intravenous immunization with influenza virus (Table 2 ). It has already been shown that in BALB\c mice infected intranasally with a large volume of virus suspension, earlier and higher IgM AFC responses than IgG and IgA AFC responses are induced in the lung and spleen (Jones & Ada, 1986) . Thus, the Ig isotype pattern of AFC responses following upper respiratory infection with influenza virus is different from that following lower respiratory infection. In addition, different frequencies of IgM AFCs, IgG AFCs and IgA AFCs in the tissues of mice infected either intranasally (small volume infection) or intravenously with influenza virus suggest that the tissues have their own mechanisms involved in the Ig isotype class switch, which can be influenced by the route of immunization.
The primary antiviral IgA AFC responses following the peak (day 7 after infection) in the NALT were characterized by a decline in the number of AFCs (Fig. 2 A) in parallel with the disappearance of live virus from the nasal cavity (Fig. 4 A) . The decrease of AFCs in the NALT was also seen immunohistochemically by the decrease of IgA-bearing B cells in the lamina propria of the NALT (data not shown). In contrast, anti-HA IgA Ab responses in the nasal wash reached a maximum level (day 10) and persisted (Fig. 4 B) . This may be explained by the migration of AFCs in the NALT to other lymphoid tissues, such as spleen and bone marrow, where many AFCs are detected in later days (Justewicz et al., 1995) . IgA Ab in the serum, probably produced by the spleen and bone marrow cells, may be secreted actively into the nasal wash by the epithelial cells of nasal mucosa (Renegar & Small, 1991) . Further experimentation will be required to elucidate the persistence of AFCs secreting Ab in the absence of any exogenous antigenic stimulation.
Virus-specific AFCs were generated in the in vitro culture of NALT cells from normal mice infected with influenza virus (Fig. 3 A) . This fact suggests that NALT is a site for AFC generation from specific B cell precursors. It has already been postulated that soluble antigens may easily penetrate the whole nasal epithelium, while particulate antigens are taken up by specialized epithelial cells, the microfold or M cells, and reach NALT (Kuper et al., 1992 ; Spit et al., 1989) . The lymphatic drainage of the nasal mucosa occurs predominantly to the superficial CLNs, while the lymphatic drainage of NALT occurs predominantly to the posterior CLNs, which are the site of generation of IgA AFCs. This suggests that NALT is the site for priming of B cells which drain to posterior CLNs where IgA AFCs are generated. The present study has added new evidence that NALT was also a site of AFC development from specific B cell precursors.
In the present experiments, it was shown that the level of IgA Abs in the nasal wash correlated with virus clearance during primary infection (Fig. 4 A, B) . This fact suggests that IgA Abs induced by virus infection are the mediators of virus clearance. In addition, the appearance of influenza virus-Ab immune complexes in the nasal wash at the time of clearance may support this notion (Fig. 5) . With respect to the presence of virus-Ab immune complexes at the time of virus clearance, Corthier & Vannier (1983) have already reported that rotavirus and IgA (or IgM) immune complexes appear in the faeces of newborn piglets on day 4 after inoculation when the production of rotavirus begins to decrease, and complex levels reach a peak when no rotavirus can be detected in the faeces. These findings are consistent with the concept that IgA Abs neutralize the infectivity of viruses present in mucosal secretions and are responsible for clearance of infectious virus from such secretions (Outlaw & Dimmock, 1990 Tamura et al., 1991) .
We have shown previously that intranasal influenza virus infection induces CD8 + cytotoxic T lymphocytes (CTLs) in nasal lymphocytes around day 7 after infection (Asanuma et al., 1995) which cannot function to prevent infection, but must function to eliminate infected cells (Yap et al., 1978 ; McMichael, 1994) . In addition, we have shown that intranasal immunization with adjuvant-combined influenza virus nucleoprotein accelerated virus clearance in the presence of CD4 + T cells, capable of producing IFN-γ and mediating delayed-type hypersensitivity, suggesting that Th1 cells could be involved in virus clearance (Tamura et al., 1996 ; Cher & Mosmann, 1987 ; Mosmann & Coffman, 1989) . Whether these CD8 + CTLs or Th1 cells are involved in virus clearance during S.-i. Tamura and others S.-i. Tamura and others intranasal virus infections or immunization with adjuvantcombined vaccine remains to be determined. In this regard, some investigators have reported that mice rendered deficient in CTL or Th cell responses are able to clear virus infection in a manner similar to their fully immunocompetent counterparts, suggesting that the mucosal Abs can clear virus-infected cells from mucosal surfaces independently of CTL or Th lymphocytes (Lightman et al., 1987 ; Eichelberger et al., 1991) . Others have reported that mice, immunosuppressed from birth with anti-mouse IgM, are able to recover from influenza virus infection in the absence of detectable nasal and serum Abs, suggesting that T cell function is essential for permanent recovery, but that Abs can speed the recovery process (Kris et al., 1985) . These data may indicate that the immune system is functionally redundant ; multiple components from both the Ab-and T cell-mediated immune systems may contribute to clearance of infection.
